| PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis (NCT04886726) | Henry Ford Health System | 2021-12-23 |
| AV-101 Alone and in Combination With Probenecid in Healthy Subjects (NCT05280054) | VistaGen Therapeutics, Inc. | 2021-12-23 |
| Food Effect and Mass Balance Study of XZP-3621 Tablets (NCT05034120) | Xuanzhu Biopharmaceutical Co., Ltd. | 2021-12-23 |
| Phase I BLASST-3 Trial (NCT04972253) | Guru P. Sonpavde | 2021-12-23 |
| A Study of DeTIL-0255 in Adults With Advanced Malignancies (NCT05107739) | Nurix Therapeutics, Inc. | 2021-12-22 |
| Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma (NCT05201326) | Ruijin Hospital | 2021-12-22 |
| Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus (NCT05158244) | Pfizer | 2021-12-22 |
| The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine. (NCT05043311) | Sinocelltech Ltd. | 2021-12-22 |
| Study of AK119 in Subjects With Advanced Solid Tumors (NCT05173792) | Akeso | 2021-12-22 |
| Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2 (NCT05203497) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2021-12-22 |
| A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. (NCT05205252) | Epizyme, Inc. | 2021-12-22 |
| Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances (NCT04623567) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2021-12-22 |
| A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis (NCT05184816) | Memorial Sloan Kettering Cancer Center | 2021-12-22 |
| The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine. (NCT05043285) | Sinocelltech Ltd. | 2021-12-22 |
| Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula (NCT05402748) | Tehran University of Medical Sciences | 2021-12-22 |
| A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma (NCT05271682) | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 2021-12-22 |
| Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors (NCT05071209) | National Cancer Institute (NCI) | 2021-12-22 |
| HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome (NCT05127226) | Ionis Pharmaceuticals, Inc. | 2021-12-22 |
| A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas (NCT05113069) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-12-22 |
| A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects (NCT05188378) | Celltrion | 2021-12-22 |
| Addition of Probenecid to Penicillin-V Therapy (NCT05082909) | Imperial College London | 2021-12-21 |
| A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People (NCT05117294) | Astellas Pharma Global Development, Inc. | 2021-12-21 |
| Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects (NCT05106205) | Dong-A ST Co., Ltd. | 2021-12-21 |
| A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants (NCT05156034) | Sarkana Pharma Inc | 2021-12-21 |
| EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC (NCT05075577) | ESSA Pharmaceuticals | 2021-12-21 |
| Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients (NCT05098613) | University of Colorado, Denver | 2021-12-21 |
| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer (NCT05041101) | M.D. Anderson Cancer Center | 2021-12-21 |
| Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors (NCT05018273) | Nykode Therapeutics ASA | 2021-12-21 |
| A Study of HB0030 Injection in Patients With Advanced Solid Tumors (NCT05706207) | Huabo Biopharm Co., Ltd. | 2021-12-21 |
| Study of SIAN Nasal Spray in Healthy Adults (NCT05194358) | Emergent BioSolutions | 2021-12-21 |
| A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rifampicin Capsules (RIF) (NCT07002255) | Henan Genuine Biotech Co., Ltd. | 2021-12-20 |
| Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide (NCT05060627) | PETHEMA Foundation | 2021-12-20 |
| Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans (NCT04769206) | Vanderbilt University Medical Center | 2021-12-20 |
| A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population (NCT05173883) | Cutia Therapeutics（Wuxi）Co.,Ltd | 2021-12-20 |
| A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy Subjects (NCT05575297) | Seoul National University Hospital | 2021-12-20 |
| Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers (NCT05588531) | Nanjing Yoko Biomedical Co., Ltd. | 2021-12-20 |
| EBRT + Lu-PSMA for N1M0 Prostate Cancer (NCT05162573) | The Netherlands Cancer Institute | 2021-12-20 |
| Effectivity and Safety of Combination of Spent Grain Wax, Argan Oil, Shea Butter and Saccharide Isomerate (NCT05186246) | Dr.dr.Irma Bernadette, SpKK (K) | 2021-12-20 |
| Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers (NCT05249348) | PMV Pharmaceuticals, Inc | 2021-12-20 |
| Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL (NCT05557903) | Lanzhou Institute of Biological Products Co., Ltd | 2021-12-20 |
| A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors (NCT05144061) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-12-20 |
| A Trial of HR17031 Injection With Hepatic Insufficiency (NCT05151705) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-20 |
| A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors (NCT05149027) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-12-20 |
| Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects (NCT05247528) | E-Star BioTech, LLC | 2021-12-20 |
| Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine (NCT05109559) | Mahidol University | 2021-12-20 |
| Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT04533750) | National Cancer Institute (NCI) | 2021-12-20 |
| Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver (NCT05182112) | Memorial Sloan Kettering Cancer Center | 2021-12-20 |
| Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors (NCT05156203) | Taivex Therapeutics Corporation | 2021-12-19 |
| Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers (NCT05132049) | Dong-A ST Co., Ltd. | 2021-12-18 |
| A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) (NCT05067283) | Merck Sharp & Dohme LLC | 2021-12-17 |
| Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate (NCT05181007) | Haisco Pharmaceutical Group Co., Ltd. | 2021-12-17 |
| Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD (NCT04500847) | Butler Hospital | 2021-12-17 |
| Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors (NCT05423977) | Hangzhou Adcoris Biopharmacy Co., Ltd | 2021-12-17 |
| Clinical Trial of WBC100 on Advanced Solid Tumor (NCT05100251) | Zhejiang University | 2021-12-17 |
| Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility) (NCT05224843) | Yale University | 2021-12-17 |
| A Safety Study of AZD4041 in Healthy Participants (NCT05233085) | AstraZeneca | 2021-12-17 |
| A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects (NCT05049083) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-17 |
| Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1 (NCT04874194) | M.D. Anderson Cancer Center | 2021-12-17 |
| A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem (NCT05106153) | Janssen Research & Development, LLC | 2021-12-17 |
| Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia (NCT05066165) | Intellia Therapeutics | 2021-12-17 |
| A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome (NCT04978779) | Vincerx Pharma, Inc. | 2021-12-16 |
| Study of Ruxolitinib Cream in Children With Atopic Dermatitis (NCT05034822) | Incyte Corporation | 2021-12-16 |
| Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function (NCT05185011) | Vigonvita Life Sciences | 2021-12-16 |
| Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies (NCT04599634) | National Cancer Institute (NCI) | 2021-12-16 |
| Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer (NCT04989946) | University of Wisconsin, Madison | 2021-12-16 |
| DDI Study of Orelabrutinib (NCT05316857) | Beijing InnoCare Pharma Tech Co., Ltd. | 2021-12-16 |
| A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19 (NCT05167279) | Shanghai Junshi Bioscience Co., Ltd. | 2021-12-16 |
| Food Effect of VS-6766 in Healthy Adult Subjects (NCT05187169) | Verastem, Inc. | 2021-12-16 |
| A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists (NCT05110976) | AstraZeneca | 2021-12-16 |
| Proximod Pharmacokinetics in Healthy Subjects and Patients With Rheumatoid Arthritis (NCT06361199) | Longevity Inc. | 2021-12-16 |
| Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers (NCT05111262) | Washington University School of Medicine | 2021-12-16 |
| COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19 (NCT05092581) | Regeneron Pharmaceuticals | 2021-12-16 |
| BK With VST for Kidney Transplant Patients (NCT05042076) | University of Wisconsin, Madison | 2021-12-16 |
| Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS (NCT04849910) | Vor Biopharma | 2021-12-16 |
| Study of RP-6306 With Gemcitabine in Advanced Solid Tumors (NCT05147272) | Debiopharm International SA | 2021-12-16 |
| Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. (NCT04896320) | Providence Health & Services | 2021-12-15 |
| Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) (NCT05182385) | Goethe University | 2021-12-15 |
| Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis (NCT04976140) | Paean Biotechnology Inc. | 2021-12-15 |
| Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment (NCT04953897) | Taiho Oncology, Inc. | 2021-12-15 |
| Tissue Engineered Veins in Patients With Chronic Venous Insufficiency (NCT03784131) | Verigraft AB | 2021-12-15 |
| Analgesic and Subjective Effects of Terpenes (NCT04451863) | University of California, Los Angeles | 2021-12-15 |
| Pentoxifylline for Treatment of Resistant Major Depression (NCT05324735) | Hawler Medical University | 2021-12-15 |
| A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas (NCT04986865) | Antengene Biologics Limited | 2021-12-15 |
| A Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB104 and Assess the Effect of Food on the Pharmacokinetics of BIIB104 Following Administration of a Single, Fixed, Oral Dose of BIIB104 in Healthy Participants (NCT05152485) | Biogen | 2021-12-15 |
| Effect of Oral Melatonin on Postoperative Analgesia After Thoracotomy in Infants (NCT05141344) | Cairo University | 2021-12-15 |
| Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. (NCT05615142) | Sichuan University | 2021-12-15 |
| A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL (NCT05138458) | Myeloid Therapeutics | 2021-12-15 |
| Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task (NCT04778644) | Hartford Hospital | 2021-12-15 |
| A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants (NCT05162222) | Bristol-Myers Squibb | 2021-12-15 |
| Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants (NCT05213481) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2021-12-15 |
| LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma (NCT04219319) | The First Affiliated Hospital with Nanjing Medical University | 2021-12-15 |
| Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS (NCT04901416) | Coeptis Therapeutics | 2021-12-15 |
| An Evaluation of 9MW1911 Injection in Healthy Subjects (NCT05803902) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2021-12-15 |
| Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors (NCT05176483) | Exelixis | 2021-12-14 |
| Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma (NCT04019262) | John Flickinger | 2021-12-14 |
| A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT05252364) | Hinova Pharmaceuticals Aus Pty Ltd | 2021-12-14 |
| Phase 1 Study to Evaluate the Safety and Tolerability of VK2735 (NCT05203237) | Viking Therapeutics, Inc. | 2021-12-14 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers (NCT05201690) | Vigonvita Life Sciences | 2021-12-14 |
| Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (NCT04809766) | Fred Hutchinson Cancer Center | 2021-12-14 |
| Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis (NCT05099445) | Incyte Corporation | 2021-12-14 |